贵州医科大学学报

2019, v.44;No.227(08) 950-954

[打印本页] [关闭]
本期目录(Current Issue) | 过刊浏览(Archive) | 高级检索(Advanced Search)

帕瑞昔布钠对乳腺癌患者外周血CD4~+CD25~+调节性T 细胞的影响
The Effects of Parecoxib Sodium on Peripheral Blood CD4~+ CD25~+ Regulatory T Cells in Patients with Breast Cancer

李志艺,颜振艺,刘晓燕,李大桁
LI Zhiyi,YAN Zhenyi,LIU Xiaoyan,LI Daheng

摘要(Abstract):

目的:探讨COX-2抑制剂帕瑞昔布钠对乳腺癌患者外周血CD4~+CD25~+调节性T细胞的影响。方法:40例Ⅱ期乳腺癌患者均分为观察组和对照组,于手术切皮前15 min,观察组给予帕瑞昔布钠40 mg、对照组给予等量生理盐水;于麻醉诱导前30 min(T1)、术毕(T2)及术后48 h(T3)抽取患者外周血,采用流式细胞术检测CD4~+CD25~+Treg细胞的含量,采用ELISA检测血清转化生长因子β(TGFβ)及白细胞介素-10(IL-10)水平。结果:对照组T2、 T3时点的CD4~+CD25~+Treg细胞比例、血清TGFβ及IL-10水平均较T1时点显著升高(P<0.01),观察组T2、T3时点的CD4~+CD25~+Treg细胞比例、血清TGFβ及IL-10水平均较同时点对照组显著降低(P<0.01)。结论:帕瑞昔布钠可抑制手术诱导的乳腺癌患者外周血CD4~+CD25~+Treg细胞比例及血清TGFβ、IL-10水平的上调。
Objective: COX-2 inhibitor parecoxib sodium can inhibit the metastasis of breast cancer by inhibiting the production of CD4+CD25+ regulatory T cells(Treg).This study intends to investigate the effects of COX-2 inhibitor parecoxib sodium on CD4~+CD25~+Treg cells in patients with breast cancer.Methods:Forty patients with stageⅡbreast cancer were randomly divided into the parecoxib sodium group and the control group.The observation group was given 40 mg of parecoxib sodium and the control group was given equal the same volume of normal saline 15 min before skin incision.Peripheral blood of patients was collected 30 min before induction of anesthesia(T1),at the end of operation(T2),and 48 h after operation(T3).The amount of CD4~+ CD25~+Treg cells was detected by flow cytometry,and serum TGFβ and IL-10 levels were detected by ELISA.Results:At the end of operation(T2) and 48 h after operation(T3),the proportion of CD4~+CD25~+Treg cells and serum TGFβ and IL-10 levels in the control group were significantly higher than those before anesthesia induction(T1)(P<0.01).The proportion of CD4~+CD25~+Treg cells in the parecoxib sodium group at the end of operation(T2) and 48 h after operation(T3) was significantly lower than that in the control group(P<0.01).At the end of operation(T2) and 48 h after operation(T3),the content of TGFβ and IL-10 in the control group was significantly higher than that before anesthesia induction(T1)(P<0.01).Compared with the control group,the content of TGFβ and IL-10 in the parecoxib sodium group was significantly reduced at the end of operation(T2) and 48 h after operation(T3)(P<0.01).Conclusion:The surgical process results in a significant increase in CD4~+CD25~+ regulatory T cells in peripheral blood of patients with breast cancer.Parecoxib sodium inhibits the proportion of CD4~+CD25~+ regulatory T cells and the levels of TGFβ and IL-10 in patients with breast cancer.

关键词(KeyWords): 帕瑞昔布钠;COX-2抑制剂;乳腺肿瘤;癌,导管,乳腺;T淋巴细胞;转化生长因子β;白细胞介素10
parecoxib sodium;COX-2 inhibitor;breastneoplasms;carcinoma,duct,breast;T-lymphocytes;transforming growth factor β;interluekin 10

Abstract:

Keywords:

基金项目(Foundation): 湛江市科技计划项目(2015B101)

作者(Author): 李志艺,颜振艺,刘晓燕,李大桁
LI Zhiyi,YAN Zhenyi,LIU Xiaoyan,LI Daheng

DOI: 10.19367/j.cnki.1000-2707.2019.08.017

参考文献(References):

文章评论(Comment):

序号(No.) 时间(Time) 反馈人(User) 邮箱(Email) 标题(Title) 内容(Content)
反馈人(User) 邮箱地址(Email)
反馈标题(Title)
反馈内容(Content)
扩展功能
本文信息
服务与反馈
本文关键词相关文章
本文作者相关文章
中国知网
分享